Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.
发明人:
Yinon Ben-Neriah,Waleed Minzel,Guy Brachya
申请号：
US16228630
公开号：
US20190365754A1
申请日:
2018.12.20
申请国别(地区):
US
年份:
2019
代理人:
摘要：
A method of treating cancer in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of a Casein kinase I alpha (CKlalpha) inhibitor, wherein the cancer is not associated with an Adenomatous polyposis coli (APC) mutation. Additional uses of CKI inhibitors are also disclosed.
